{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:01:17Z","timestamp":1759341677807},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.medcli.2016.10.005","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T03:00:18Z","timestamp":1480561218000},"page":"176-180","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Actualizaci\u00f3n del diagn\u00f3stico y el tratamiento de la leucemia\/linfoma T del adulto"],"prefix":"10.1016","volume":"148","author":[{"given":"Santiago","family":"Mercadal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Sureda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Gonz\u00e1lez-Barca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2016.10.005_bib0165","series-title":"Virus taxonomy. Sixth report of the International Committee on Taxonomy of Viruses","first-page":"193","article-title":"Family Retroviridae","author":"Coffin","year":"1995"},{"key":"10.1016\/j.medcli.2016.10.005_bib0170","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1136\/jcp.2007.052662","article-title":"Molecular aspects of HTLV-I infection and adult T-cell leukaemia\/lymphoma","volume":"60","author":"Taylor","year":"2007","journal-title":"J Clin Pathol."},{"key":"10.1016\/j.medcli.2016.10.005_bib0175","doi-asserted-by":"crossref","first-page":"282","DOI":"10.5858\/arpa.2012-0379-RS","article-title":"Adult T-cell leukemia\/lymphoma","volume":"138","author":"Qayyum","year":"2014","journal-title":"Arch Pathol Lab Med."},{"key":"10.1016\/j.medcli.2016.10.005_bib0180","unstructured":"Vendranes Mata M, Mercadal Vilchez S, de la Banda Ledrado E, Climent Esteller J, Encuentra Mart\u00ed M, Casanovas L\u00f3pez E, et al. Caracter\u00edsticas cl\u00ednico-biol\u00f3gicas de la leucemia\/linfoma de c\u00e9lulas T del adulto (LLTA): experiencia de 5 casos en un \u00fanico centro. LVI Congreso Nacional de la Sociedad Espa\u00f1ola de Hematolog\u00eda y Hemoterapia. Madrid, 6-8 noviembre de 2014. PO-163."},{"key":"10.1016\/j.medcli.2016.10.005_bib0185","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/jcp.2007.052456","article-title":"Adult T-cell leukaemia\/lymphoma","volume":"60","author":"Matutes","year":"2007","journal-title":"J Clin Pathol."},{"key":"10.1016\/j.medcli.2016.10.005_bib0190","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1182\/blood-2011-03-345702","article-title":"How I treat adult T-cell leukemia\/lymphoma","volume":"118","author":"Bazarbachi","year":"2011","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2016.10.005_bib0195","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2016.10.005_bib0200","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","article-title":"A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303","volume":"113","author":"Yamada","year":"2001","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2016.10.005_bib0205","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: A proposal from an international consensus meeting","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2016.10.005_bib0210","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-4690-10-52","article-title":"Interferon-alpha (IFN-alpha) suppresses HTLV-1 gene expression and cell cycling, while IFN-alpha combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells","volume":"10","author":"Kinpara","year":"2013","journal-title":"Retrovirology."},{"key":"10.1016\/j.medcli.2016.10.005_bib0215","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11899-012-0139-9","article-title":"\u201cAntivirals\u201d in the treatment of adult T cell leukaemia-lymphoma (ATLL)","volume":"7","author":"Fields","year":"2012","journal-title":"Curr Hematol Malig Rep."},{"key":"10.1016\/j.medcli.2016.10.005_bib0220","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","article-title":"Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes","volume":"28","author":"Bazarbachi","year":"2010","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2016.10.005_bib0225","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2016.10.005_bib0230","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1200\/JCO.2011.35.5578","article-title":"Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia\/lymphoma","volume":"29","author":"Hodson","year":"2011","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2016.10.005_bib0235","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1182\/blood-2009-03-211821","article-title":"Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia\/lymphoma (ATL)","volume":"113","author":"Kchour","year":"2009","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2016.10.005_bib0240","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/sj.thj.6200374","article-title":"Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed\/refractory adult T-cell leukemia\/lymphoma","volume":"5","author":"Hermine","year":"2004","journal-title":"Hematol J."},{"key":"10.1016\/j.medcli.2016.10.005_bib0245","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3324\/haematol.10703","article-title":"Therapeutic potential of arsenic trioxide with or without interferon-alpha for relapsed\/refractory adult T-cell leukemia\/lymphoma","volume":"92","author":"Ishitsuka","year":"2007","journal-title":"Haematologica."},{"key":"10.1016\/j.medcli.2016.10.005_bib0250","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.bmt.1701533","article-title":"Poor outcome of autologous stem cell transplantation for adult T cell leukemia\/lymphoma: A case report and review of the literature","volume":"23","author":"Tsukasaki","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.medcli.2016.10.005_bib0255","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/bmt.2014.143","article-title":"Outcome of patients with HTLV-1-associated adult T-cell leukemia\/lymphoma after SCT: A retrospective study by the EBMT LWP","volume":"49","author":"Bazarbachi","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.medcli.2016.10.005_bib0260","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1182\/blood-2012-03-414490","article-title":"Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: A nationwide retrospective study","volume":"120","author":"Ishida","year":"2012","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2016.10.005_bib0265","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","article-title":"Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: A nationwide retrospective study","volume":"116","author":"Hishizawa","year":"2010","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2016.10.005_bib0270","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1200\/JCO.2009.25.3575","article-title":"Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma","volume":"28","author":"Yamamoto","year":"2010","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2016.10.005_bib0275","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/bjh.13338","article-title":"Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: A randomized phase ii study","volume":"169","author":"Ishida","year":"2015","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2016.10.005_bib0280","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.leukres.2011.12.004","article-title":"Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia\/lymphoma (ATLL)","volume":"36","author":"Ceesay","year":"2012","journal-title":"Leuk Res."},{"issue":"Suppl 1","key":"10.1016\/j.medcli.2016.10.005_bib0285","doi-asserted-by":"crossref","first-page":"P8","DOI":"10.1186\/1742-4690-11-S1-P8","article-title":"Case reports: Combination therapy with proteasome inhibitor Bortezomib and humanized anti-CD25 Basiliximab for treatment of adult T cell leukaemia lymphoma","volume":"11","author":"Kagdi","year":"2014","journal-title":"Retrovirology."},{"key":"10.1016\/j.medcli.2016.10.005_bib0290","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/sj.leu.2403400","article-title":"Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro","volume":"18","author":"Satou","year":"2004","journal-title":"Leukemia."},{"key":"10.1016\/j.medcli.2016.10.005_bib0295","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/cas.12735","article-title":"A phase ii study of bortezomib in patients with relapsed or refractory aggressive adult T-cell leukemia\/lymphoma","volume":"106","author":"Ishitsuka","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.medcli.2016.10.005_bib0300","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.3109\/10428194.2013.780289","article-title":"Bortezomib salvage therapy in refractory acute adult T-cell leukemia\/lymphoma","volume":"54","author":"Hourigan","year":"2013","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.medcli.2016.10.005_bib0305","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1038\/bcj.2016.21","article-title":"Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma","volume":"25","author":"Ratner","year":"2016","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.medcli.2016.10.005_bib0310","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/S2352-3026(15)00284-7","article-title":"Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): A phase 1, multicentre, dose-escalation study","volume":"3","author":"Ogura","year":"2016","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.medcli.2016.10.005_bib0315","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/blood-2012-05-427773","article-title":"Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia","volume":"121","author":"Chen","year":"2013","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2016.10.005_bib0320","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.leukres.2007.05.026","article-title":"Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor kappaB","volume":"32","author":"Nishioka","year":"2008","journal-title":"Leuk Res."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775316305140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775316305140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T08:26:05Z","timestamp":1536222365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775316305140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0025775316305140"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2016.10.005","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actualizaci\u00f3n del diagn\u00f3stico y el tratamiento de la leucemia\/linfoma T del adulto","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2016.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}